Project Details
Description
An Open-label, Phase II, Multicenter Study of Intravenous Weekly Topotecan in Subjects with Recurrent or Persistent Endometrial Cancer HCT100414
| Status | Finished |
|---|---|
| Effective start/end date | 10/19/05 → 1/30/08 |
Funding
- GLAXOSMITHKLINE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.